Trimethoprim-Sulfamethoxazole or Pentamidine for Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency Syndrome

Wharton, J. Marcus; Coleman, Diana Lewis; Wofsy, Constance B.; Luce, John M.; Blumenfeld, Walter; Hadley, W. Keith; Ingram-Drake, Leslie; Volberding, Paul A.; Hopewell, Philip C.
July 1986
Annals of Internal Medicine;Jul86, Vol. 105 Issue 1, p37
Academic Journal
Presents a study that examined the efficacy of trimethoprim-sulfamethoxazole or pentamidine isethionate for the treatment of Pneumocystis carinii pneumonia in patients with AIDS. Medical history of the patients; Methodology; Results and discussion.


Related Articles

  • Trimethoprim--Sulfamethoxazole Compared with Pentamidine for Treatment of Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency Syndrome. Sattler, Fred R.; Cowan, Robert; Nielsen, Donald M.; Ruskin, Joel // Annals of Internal Medicine;8/15/88, Vol. 109 Issue 4, p280 

    Ascertains the efficacy and toxicity of trimethoprim-sulfamethoxazole or pentamidine during the treatment period for Pneumocystis carinii pneumonia in patients with AIDS. Adverse drug effects; Dosage and treatment modifications; Determinants of toxicity; Effect of increased severity of illness.

  • Cotrimoxazole.  // Reactions Weekly;1/21/2017, Vol. 1635 Issue 1, p95 

    An abstract of the article "Successful treatment of severe Pneumocystis pneumonia in an immunosuppressed patient using caspofungin combined with clindamycin: A case report and literature review" by H. Li and others is presented.

  • Dapsone-Trimethoprim for Pneumonia in the Acquired Immunodeficiency Syndrome. Leoung, Clifford S.; Mills, John; Hopewell, Philip C.; Hughes, Walter; Wofsy, Constance // Annals of Internal Medicine;Jul86, Vol. 105 Issue 1, p45 

    Presents a study that examined the efficacy of dapsone plus trimethoprim for the treatment of patients with AIDS and a first episode of Pneumocystis carinii pneumonia. Methodology; Characteristics of patients with AIDS and Pneumocystis carinii pneumonia treated with dapsone-trimethoprim;...

  • Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study. Helweg-Larsen, Jannik; Benfield, Thomas; Atzori, Chiara; Miller, Robert F. // Journal of Antimicrobial Chemotherapy (JAC);Dec2009, Vol. 64 Issue 6, p1282 

    Objectives: First-line therapy for Pneumocystis jirovecii pneumonia (PCP) is trimethoprim/sulfamethoxazole. Few data exist to guide the choice of second-line therapy for patients failing or developing toxicity to first-line therapy.

  • DALLAS GAYS SET UP 'GUERRILLA' AIDS CLINIC. Vandervelden, Mark // Advocate;4/26/88, Issue 497, p14 

    Reports on the dispensation of aerosol pentamidine isethionate at the Dallas AIDS Resource Center, Texas. Pentamidine isethionate as experimental drug for the treatment of Pneumocystis carinii pneumonia; Refusal of Parkland Memorial Hospital in Dallas County to administer the drug; Dallas Gay...

  • Par Pharmaceutical Gains Rights To Phase III Drug From Immtech. Shrine, Jim // BioWorld Today;6/13/2007, Vol. 18 Issue 114, p1 

    The article reports that Par Pharmaceutical Cos. Inc. acquired exclusive rights in the U.S. to a Phase III drug from Immtech Pharmaceuticals Inc. for treating pneumocystis pneumonia in acquired immune deficiency syndrome (AIDS) patients. The goal of the Phase III study is to demonstrate...

  • Bacterial resistance to TMP-SMX up markedly, particularly among HIV-infected patients.  // Formulary;Feb2000, Vol. 35 Issue 2, p190 

    Discusses the report `Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era,' by J.N. Martin, D.A. Rose and W.K. Hadley, which appeared in a 1999 issue of `Journal of Infectious Diseases.'

  • Resistance to Trimethoprim-Sulfamethoxazole. Huovinen, Pentti // Clinical Infectious Diseases;6/1/2001, Vol. 32 Issue 11, p1608 

    Discusses the use of trimethoprim (TMP)-sulfamethoxazole as treatment and prophylaxis of patients with urinary tract infections. Mechanisms of bacterial resistance; Use of TMP and sulfonamides.

  • Low--Dose Trimethoprim--Sulfamethoxazole Prophylaxis for Toxoplasmic Encephalitis in Patients with AIDS. Carr, Andrew; Tindall, Brent; Brew, Bruce J.; Marriott, Deborah J.; Harkness, John L.; Penny, Ronald; Cooper, David A. // Annals of Internal Medicine;7/15/92, Vol. 117 Issue 2, p106 

    Focuses on a study which determined the efficacy of low-dose trimethoprim-sulfamethoxazole as primary prophylaxis against toxoplasmic encephalitis in patients with HIV infection. Information on toxoplasmic encephalitis; Methodology of the study; Results and discussion.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics